 |
|
|
| |
Ledipasvir/Sofosbuvir for 12 Weeks Is Safe and Effective in Children 3
to <6 years old with Chronic Hepatitis C Virus Infection
|
| |
| |
Reported by Jules Levin
AASLD 2018 Nov 9-13 San Francisco
Kathleen B. Schwarz1, Philip Rosenthal2, Karen F. Murray3, Jonathan R. Honegger4, Winita Hardikar5, Rosie Hague6, Naveen Mittal7, Benedetta Massetto8, Diana M. Brainard8, Rebecca Begley8, Jiang Shao8, Bandita Parhy8, Michael Narkewicz9, Girish S. Rao10, Suzanne Whitworth11, Sanjiay Bansal12, William Balistreri13
1Johns Hopkins Hospital, Baltimore, MD; 2University of California San Francisco, CA; 3University of Washington School of Medicine and Seattle Children's Hospital, Seattle, WA; 4The Ohio State University Medical Center, Columbus, OH; 5The Royal Children's Hospital, Melbourne, VIC, Australia; 6Royal Hospital for Children, Glasgow, UK; 7Texas Liver Institute, San Antonio, TX; 8Gilead Sciences Inc., Foster City, CA; 9Children's Hospital of Colorado, Aurora, CO; 10Riley Hospital for Children, Indianapolis, IN; 11Cook Children's Health Care System, Fort Worth, TX; 12King's College Hospital, London, UK; 13Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, OH
|
| |
|
|
|
|
|
